Indo-Bangla Pharmaceuticals (DHA:IBP) Interest Expense: BDT Mil (TTM As of . 20)


DHA:IBP Indo-Bangla Pharmaceuticals Ltd DHA:IBP
32 GF Score
Price BDT17.90
View Full Analysis

What is Indo-Bangla Pharmaceuticals Interest Expense?

Indo-Bangla Pharmaceuticals DHA:IBP +1.70% 32 Interest Expense is BDT Mil as of . 20. GuruFocus rates DHA:IBP with a GF Score™ of 32/100.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Indo-Bangla Pharmaceuticals's interest expense for the six months ended in . 20 was BDT 0.00 Mil. Indo-Bangla Pharmaceuticals does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Indo-Bangla Pharmaceuticals's Operating Income for the six months ended in . 20 was BDT 0.00 Mil. Indo-Bangla Pharmaceuticals's Interest Expense for the six months ended in . 20 was BDT 0.00 Mil. Indo-Bangla Pharmaceuticals did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Indo-Bangla Pharmaceuticals  (DHA:IBP) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Indo-Bangla Pharmaceuticals's Interest Expense for the six months ended in . 20 was BDT0.00 Mil. Its Operating Income for the six months ended in . 20 was BDT0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was BDT0.00 Mil.

Indo-Bangla Pharmaceuticals's Interest Coverage for the quarter that ended in . 20 is calculated as

Indo-Bangla Pharmaceuticals had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Indo-Bangla Pharmaceuticals Interest Expense Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals Interest Expense Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
Interest Expense

Indo-Bangla Pharmaceuticals Semi-Annual Data
Interest Expense
DHA:IBP
32GF Score
Indo-Bangla Pharmaceuticals Ltd DHA:IBP
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo-Bangla Pharmaceuticals Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of BDT Mil mean?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a Interest Expense of BDT Mil as of . 20. Interest Expense is the amount a company pays on its long-term debt. View historical data on Indo-Bangla Pharmaceuticals and its competitors.
Is Indo-Bangla Pharmaceuticals' Interest Expense too high?
Indo-Bangla Pharmaceuticals' current Interest Expense is BDT Mil. Overall, Indo-Bangla Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Indo-Bangla Pharmaceuticals' Interest Expense compare to ?
Indo-Bangla Pharmaceuticals' Interest Expense of BDT Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Indo-Bangla Pharmaceuticals and its competitors. Indo-Bangla Pharmaceuticals's current Interest Expense is BDT Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo-Bangla Pharmaceuticals stock overvalued right now?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a current Interest Expense of BDT Mil. The current Interest Expense is BDT Mil. Indo-Bangla Pharmaceuticals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Indo-Bangla Pharmaceuticals (DHA:IBP), the current Interest Expense is BDT Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.
32GF Score

Get the complete analysis for DHA:IBP

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT17.90
Price